DEA Reiterates: Lab-Derived Cannabinoids Are Not Compliant With Farm Bill
May 10, 2026
The agency has been consistent in its interpretation of the law, but federal courts have disagreed
The agency has been consistent in its interpretation of the law, but federal courts have disagreed
An update on the Trump administration’s rescheduling announcement
Study found “vaporization of cannabis flower reduced exposure to these harmful compounds by up to 99 percent compared with joint smoke”
“Results suggest light prenatal alcohol and cannabis use are not associated with long-term negative cognitive outcomes during adolescence”
The order also states that “unlicensed bulk marijuana” remains classified as a Schedule I controlled substance
The study’s results are consistent with those of others finding no next-day driving impairment
“Eligible hemp products must be furnished and provided directly by a qualified physician affiliated with the participant organization.”
“Those considering legalization should wait a few years before pronouncing on the cost-benefit impact.”
Data from the Massachusetts Cannabis Control Commission shows that over 70% of consumers purchase their cannabis at a store
Conclusions are nearly identical to a study comparing drivers who abstained from cannabis for 48 hours to that of non-users
